Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scar

Cardiovascular Revascularization Medicine

Volumn 12, Issue 2, 2011, Pages 111-122

  Saeed, Maythem ^a   Saloner, David ^a   Do, Loi ^a   Wilson, Mark ^a   Martin, Alastair ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Gene therapy; Interventional cardiology; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

SCATTER FACTOR;

ANGIOGENESIS; ARTICLE; CONTRAST ENHANCEMENT; FLUOROSCOPY; GENE TARGETING; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SWINE;

ANIMALS; CHRONIC DISEASE; CICATRIX; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; GENETIC THERAPY; HEPATOCYTE GROWTH FACTOR; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; STROKE VOLUME; SWINE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79952732766     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.05.003     Document Type: Article

References (36)

1. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR, Chaitman BR, Kaiser GC, Alderman E, Killip T Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994, 90(6):2645-2657.
2. Kramer CM, Lima JA, Reichek N, Ferrari VA, Llaneras MR, Palmon LC, Yeh IT, Tallant B, Axel L Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993, 88(3):1279-1288.
3. Azuma J, Taniyama Y, Takeya Y, Iekushi K, Aoki M, Dosaka N, Matsumoto K, Nakamura T, Ogihara T, Morishita R Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther 2006, 13(16):1206-1213.
4. Chen XH, Minatoguchi S, Kosai K, Yuge K, Takahashi T, Arai M, Wang N, Misao Y, Lu C, Onogi H, Kobayashi H, Yasuda S, Ezaki M, Ushikoshi H, Takemura G, Fujiwara T, Fujiwara H In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. J Card Fail 2007, 13(10):874-883.
5. Saeed M, Martin A, Ursell P, Do L, Bucknor M, Higgins CB, Saloner D MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium. Radiology 2008, 249(1):107-118.
6. Fuchs S, Dib N, Cohen BM, Okubagzi P, Diethrich EB, Campbell A, Macko J, Kessler PD, Rasmussen HS, Epstein SE, Kornowski R A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease. Catheter Cardiovasc Interv 2006, 68(3):372-378.
7. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98(25):2800-2804.
8. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999, 100(5):468-474.
9. Schumacher B, Pecher P, von Specht BU, Stegmann T Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998, 97(7):645-650.
10. Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2008, 294(2):H1048-1057.
11. Hayakawa K, Takemura G, Kanoh M, Li Y, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Fujiwara T, Fujiwara H Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 2003, 108(1):104-109.
12. Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura N, Matsuda H Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002, 105(21):2556-2561.
13. Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, Hashiya N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 2002, 40(1):47-53.
14. Yang ZJ, Xu SL, Chen B, Zhang SL, Zhang YL, Wei W, Ma DC, Wang LS, Zhu TB, Li CJ, Wang H, Cao KJ, Gao W, Huang J, Ma WZ, Wu ZZ Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease. Clin Exp Pharmacol Physiol 2009, 36(8):790-796.
15. Carlsson M, Osman NF, Ursell PC, Martin AJ, Saeed M Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium. Am J Physiol Heart Circ Physiol 2008, 295(2):H522-532.
16. Cho KR, Choi JS, Hahn W, Kim DS, Park JS, Lee DS, Kim KB Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model. Eur J Cardiothorac Surg 2008, 34(4):857-863.
17. Saeed M, Martin A, Jacquier A, Bucknor M, Saloner D, Do L, Ursell P, Su H, Kan YW, Higgins CB Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model. Radiology 2008, 249(2):560-571.
18. Pyun WB, Hahn W, Kim DS, Yoo, WS, Lee SD, Won JH, Rho BS, Park ZY, Kim JM, Kim S. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia. Gene Ther 2010 (in press).
19. Furtado AD, Carlsson M, Wintermark M, Ordovas K, Saeed M Identification of residual ischemia, infarction, and microvascular impairment in revascularized myocardial infarction using 64-slice MDCT. Contrast Media Mol Imaging 2008, 3(5):198-206.
20. Dicks DL, Carlsson M, Heiberg E, Martin A, Saloner D, Arheden H, Saeed M Persistent decline in longitudinal and radial strain after coronary microembolization detected on velocity encoded phase contrast magnetic resonance imaging. J Magn Reson Imaging 2009, 30(1):69-76.
21. Neizel M, Lossnitzer D, Korosoglou G, Schaufele T, Peykarjou H, Steen H, Ocklenburg C, Giannitsis E, Katus HA, Osman NF Strain-encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction. Circ Cardiovasc Imaging 2009, 2(2):116-122.
22. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, Waksman R, Weissman NJ, Cerqueira M, Leon MB, Epstein SE Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003, 41(10):1721-1724.
23. Lund GK, Stork A, Saeed M, Bansmann MP, Gerken JH, Muller V, Mester J, Higgins CB, Adam G, Meinertz T Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 2004, 232(1):49-57.
24. Theilmeier G, Verhamme P, Dymarkowski S, Beck H, Bernar H, Lox M, Janssens S, Herregods MC, Verbeken E, Collen D, Plate K, Flameng W, Holvoet P Hypercholesterolemia in minipigs impairs left ventricular response to stress: association with decreased coronary flow reserve and reduced capillary density. Circulation 2002, 106(9):1140-1146.
25. Jacquier A, Higgins CB, Martin AJ, Do L, Saloner D, Saeed M. Injection of adeno-associated viral vector encoding vascular endothelial growth factor gene in infarcted swine myocardium: MR measurements of left ventricular function and strain. Radiology. 2007, 245(1):196-205.
26. Laguens R, Cabeza Meckert P, Vera Janavel G, De Lorenzi A, Lascano E, Negroni J, Del Valle H, Cuniberti L, Martinez V, Dulbecco E, Melo C, Fernandez N, Criscuolo M, Crottogini A Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med 2004, 6(2):222-227.
27. Duan HF, Wu CT, Wu DL, Lu Y, Liu HJ, Ha XQ, Zhang QW, Wang H, Jia XX, Wang LS Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 2003, 8(3):467-474.
28. Weidemann F, Jamal F, Kowalski M, Kukulski T, D'Hooge J, Bijnens B, Hatle L, De Scheerder I, Sutherland GR Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing-implications for quantitative stress echocardiography. J Am Soc Echocardiogr 2002, 15(5):416-424.
29. Wang X, Hu Q, Mansoor A, Lee J, Wang Z, Lee T, From AH, Zhang J Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. Am J Physiol Heart Circ Physiol 2006, 290(4):H1393-1405.
30. Yin FC Ventricular wall stress. Circ Res 1981, 49(4):829-842.
31. Wang Y, Ahmad N, Wani MA, Ashraf M Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 2004, 37(5):1041-1052.
32. Guerrero M, Athota K, Moy J, Mehta LS, Laguens R, Crottogini A, Borrelli M, Corry P, Schoenherr D, Gentry R, Boura J, Grines CL, Raff GL, Shanley CJ, O'Neill WW Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction. J Interv Cardiol 2008, 21(3):242-251.
33. Ferrarini M, Arsic N, Recchia FA, Zentilin L, Zacchigna S, Xu X, Linke A, Giacca M, Hintze TH Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006, 98(7):954-961.
34. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107(18):2290-2293.
35. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000, 106(12):1511-1519.
36. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114(1):32-39.